PROTEOLYTIC RELEASE AND CRYSTALLIZATION OF THE RNASE-H DOMAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE

被引:0
|
作者
HOSTOMSKA, Z
MATTHEWS, DA
DAVIES, JF
NODES, BR
HOSTOMSKY, Z
机构
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The RNase H domain of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase was released from recombinant DHFR-RNase H fusion protein by the action of HIV-1 protease and crystallized as large trigonal prisms that diffract x-rays to at least 2.4-angstrom resolution. The protease cleavage occurred 18 residues away from the Phe440-Tyr441 site reported to be processed during maturation of the reverse transcriptase heterodimer. Mutagenesis of the protease-sensitive region (residues 430-440), which is part of the crystallized domain, indicates that any alteration of the wild-type sequence results in increased proteolysis of the p66 subunit. A model of asymmetric processing in HIV-1 reserve transcriptase which involves partial unfolding of the RNase H domain is proposed based on these results and the recently reported three-dimensional structure of this domain.
引用
收藏
页码:14697 / 14702
页数:6
相关论文
共 50 条
  • [21] SUBSTITUTION OF A HIGHLY BASIC HELIX LOOP SEQUENCE INTO THE RNASE-H DOMAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE RESTORES ITS MN2+-DEPENDENT RNASE-H ACTIVITY
    KECK, JL
    MARQUSEE, S
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (07) : 2740 - 2744
  • [22] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE AND RIBONUCLEASE-H AS SUBSTRATES OF THE VIRAL PROTEASE
    TOMASSELLI, AG
    SARCICH, JL
    BARRETT, LJ
    REARDON, IM
    HOWE, WJ
    EVANS, DB
    SHARMA, SK
    HEINRIKSON, RL
    PROTEIN SCIENCE, 1993, 2 (12) : 2167 - 2176
  • [23] CHARACTERIZATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE ENZYME PRODUCED IN YEAST
    BATHURST, IC
    MOEN, LK
    LUJAN, MA
    GIBSON, HL
    FEUCHT, PH
    PICHUANTES, S
    CRAIK, CS
    SANTI, DV
    BARR, PJ
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 171 (02) : 589 - 595
  • [24] 2 HIGHLY ANTIGENIC SITES IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE
    BJORLING, E
    BOUCHER, CAB
    SAMUELSSON, A
    WOLFS, TFW
    UTTER, G
    NORRBY, E
    CHIODI, F
    JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (03) : 588 - 592
  • [25] ACTION OF URACIL ANALOGS ON HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND ITS REVERSE-TRANSCRIPTASE
    PIRAS, G
    DUTSCHMAN, GE
    IM, GJ
    PAN, BC
    CHU, SH
    CHENG, YC
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (02) : 539 - 541
  • [26] DIMERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE - A TARGET FOR CHEMOTHERAPEUTIC INTERVENTION
    RESTLE, T
    MULLER, B
    GOODY, RS
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1990, 265 (16) : 8986 - 8988
  • [27] THE INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE BY AVAROL AND AVARONE DERIVATIVES
    LOYA, S
    HIZI, A
    FEBS LETTERS, 1990, 269 (01) : 131 - 134
  • [28] STRUCTURAL BASIS OF ASYMMETRY IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE HETERODIMER
    WANG, J
    SMERDON, SJ
    JAGER, J
    KOHLSTAEDT, LA
    RICE, PA
    FRIEDMAN, JM
    STEITZ, TA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (15) : 7242 - 7246
  • [29] HEXAPRENOID HYDROQUINONES, NOVEL INHIBITORS OF THE REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    LOYA, S
    TAL, R
    HIZI, A
    ISSACS, S
    KASHMAN, Y
    LOYA, Y
    JOURNAL OF NATURAL PRODUCTS, 1993, 56 (12): : 2120 - 2125
  • [30] KINETICS OF DIFFERENT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE TRANSCRIPTASES RESISTANT TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-SPECIFIC REVERSE-TRANSCRIPTASE INHIBITORS
    DEBYSER, Z
    DEVREESE, K
    KNOPSGERRITS, PP
    BAEKELANDT, V
    BHIKHABHAI, R
    STRANDBERG, B
    PAUWELS, R
    ANNE, J
    DESMYTER, J
    DE CLERCQ, E
    MOLECULAR PHARMACOLOGY, 1993, 43 (04) : 521 - 526